National Health Investors (NHI) Set to Announce Earnings on Monday

National Health Investors (NYSE:NHI) is scheduled to be releasing its earnings data after the market closes on Monday, May 6th. Analysts expect National Health Investors to post earnings of $1.06 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

National Health Investors Stock Up 0.4 %

NYSE:NHI opened at $62.89 on Monday. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors has a 1-year low of $47.54 and a 1-year high of $63.37. The business’s fifty day moving average price is $59.75 and its 200 day moving average price is $55.77. The firm has a market capitalization of $2.73 billion, a price-to-earnings ratio of 20.09 and a beta of 0.95.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be paid a $0.90 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $3.60 annualized dividend and a yield of 5.72%. National Health Investors’s dividend payout ratio is presently 115.02%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research note on Tuesday, January 30th. They issued a “buy” rating and a $69.00 target price on the stock. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Truist Financial raised their target price on shares of National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research note on Thursday, April 4th. Wedbush boosted their target price on shares of National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a research report on Monday, March 18th. Finally, Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $60.50.

Insiders Place Their Bets

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was acquired at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the transaction, the director now owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 7.26% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.